πŸ“„ Springer chapter Β· 2019 Β· most-cited work

A Framework for Predicting and Identifying Radicalization and Civil Unrest Oriented Threats from WhatsApp Group

Koushik Deb, Souptik Paul, Kaustav Das Β· Emerging Technology in Modelling and Graphics (Springer AISC 937)

πŸ› SpringerπŸ“ˆ 12 citationsπŸ” Encrypted-platform challenge🧩 Framework paper
group chat everyday message… plans for the weekend inflammatory call to gather ⚠ normal reply NLP classifier threat / not-threat ! early warning

Inside a group chat, most messages are everyday noise β€” the framework listens for the pattern that isn't.

In plain words

Facebook and Twitter are studied endlessly, but WhatsApp β€” where much of the world actually organises β€” is a research blind spot: end-to-end encryption means there are almost no open datasets of group chats, even as groups have been used to spread riots and radicalization.

This chapter proposes a framework that combines NLP, semi-supervised machine learning, pattern mining and topic detection to estimate the probability that a WhatsApp group poses a civil-unrest threat. It is deliberately a framework: designed to be field-deployable, with prediction quality that scales as more real data becomes available to feed it.

How it works

  1. Acquire what's possibleWorking within encryption constraints, available group text is collected and preprocessed.
  2. Detect the topicsTopic detection surfaces what a group persistently talks about.
  3. Learn with few labelsSemi-supervised learning stretches scarce labelled examples across the unlabelled majority.
  4. Score the groupPattern mining and classification combine into a threat probability for the group as a whole.

Why it matters

Radicalization migrated to encrypted platforms precisely because nobody could watch. A principled framework for threat scoring under those constraints β€” published in 2019, before this became mainstream concern β€” is why this remains my most-cited work.

Read the chapter β†— ← All research
← PreviousDisease prediction from drug reviews (2021)